We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-8.03%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$661M
AUM Growth
-$419M
(-39%)
Cap. Flow
-$356M
Cap. Flow
% of AUM
-53.87%
Top 10 Holdings %
Top 10 Hldgs %
71.47%
Holding
175
New
36
Increased
24
Reduced
31
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Homes 4 Rent
AMH
|
+$9.19M |
| 2 |
Kilroy Realty
KRC
|
+$9.08M |
| 3 |
Travelers Companies
TRV
|
+$7.12M |
| 4 |
ROIC
Retail Opportunity Investments Corp.
ROIC
|
+$6.64M |
| 5 |
Synchrony
SYF
|
+$5.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aquestive Therapeutics
AQST
|
+$201M |
| 2 |
Denali Therapeutics
DNLI
|
+$20.2M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$11M |
| 4 |
HDP
Hortonworks, Inc.
HDP
|
+$7.46M |
| 5 |
Broadcom
AVGO
|
+$7.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.8% |
| 2 | Real Estate | 19.25% |
| 3 | Financials | 5.9% |
| 4 | Industrials | 4.47% |
| 5 | Consumer Discretionary | 3.05% |
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q4 2018 Portfolio in Review
As of Q4 2018, Crestline Management held 175 positions worth $661M, down 39% from $1.08B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Crestline Management withdrew a net $356M in Q4 2018, closing 84 positions and reducing 31 holdings. Its most notable exit was Aquestive Therapeutics, an estimated $201M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Crestline Management opened a new position in American Homes 4 Rent worth $8.92M.
- Crestline Management's largest Q4 2018 buy was American Homes 4 Rent: 449,400 shares worth $8.92M.
- Crestline Management added most to Kilroy Realty in Q4 2018, an estimated $9.08M increase.
- Crestline Management's biggest Q4 2018 reduction was Denali Therapeutics, cutting an estimated $20.2M.
- Crestline Management fully exited Aquestive Therapeutics in Q4 2018, selling an estimated $201M.
- Crestline Management's ten largest holdings make up 71% of its $661M portfolio in Q4 2018.
- Crestline Management opened 36 new positions and closed 84 in Q4 2018.
- Crestline Management's portfolio value fell 39% quarter-over-quarter to $661M.
Based on Crestline Management's 13F filing for Q4 2018, filed 14 Feb 2019.